Advertisement

Journal of Neuro-Oncology

, Volume 100, Issue 1, pp 145–149 | Cite as

Leptomeningeal gliomatosis as the initial presentation of gliomatosis cerebri

  • Matthew K. Knox
  • Cynthia Ménard
  • Warren P. Mason
Case Report

Abstract

Leptomeningeal gliomatosis is a known, yet uncommon, complication of malignant gliomas. In rare instances it can present with non-specific symptoms prior to the development of detectable intraparenchymal lesions, posing a diagnostic challenge. Gliomatosis cerebri is also a rare disease, characterized by extensive diffuse infiltration of neoplastic glial cells. For both entities, limited data exist to guide treatment and prognosis is poor. We describe the case of a patient who presented with symptoms of increased intracranial pressure and diffuse leptomeningeal enhancement in the brain and spinal cord on MRI. After a period of surveillance, intraparenchymal lesions developed in association with widespread diffuse infiltration. The diagnosis of gliomatosis cerebri with diffuse leptomeningeal gliomatosis was established in hindsight. Initial treatment consisted of six cycles of temozolomide chemotherapy. Following radiological progression, the patient received craniospinal radiotherapy. Four months later the patient’s symptoms had resolved and MRI demonstrated near complete response of leptomeningeal enhancement and intraparenchymal lesions. Six months after radiotherapy, the patient remains clinically well without radiographic recurrence.

Keywords

Leptomeningeal gliomatosis Gliomatosis cerebri Glioma Cranial irradiation 

References

  1. 1.
    Delattre JY, Walker RW, Rosenblum MK (1989) Leptomeningeal gliomatosis with spinal-cord or cauda-euina compression—a complication of supratentorial gliomas in adults. Acta Neurol Scand 79:133–139CrossRefPubMedGoogle Scholar
  2. 2.
    Vertosick FT, Selker RG (1990) Brain-stem and spinal metastases of supratentorial glioblastoma-multiforme—a clinical series. Neurosurgery 27:516–522CrossRefPubMedGoogle Scholar
  3. 3.
    Singh M, Corboy JR, Stears JC, Kleinschmidt-DeMasters BK (1998) Diffuse leptomeningeal gliomatosis associated with multifocal CNS infarcts. Surg Neurol 50:356–362CrossRefPubMedGoogle Scholar
  4. 4.
    Trivedi RA, Nichols P, Coley S, Cadoux-Hudson TAD, Donaghy M (2000) Leptomeningeal glioblastoma presenting with multiple cranial neuropathies and confusion. Clin Neurol Neurosurg 102:223–226CrossRefPubMedGoogle Scholar
  5. 5.
    Wheen LC, Anderson NE, Baker PCH, Singh VK, Synek BJL (2006) Leptomeningeal infiltration as the presenting manifestation of a malignant glioma. J Clin Neurosci 13:298–301CrossRefPubMedGoogle Scholar
  6. 6.
    Fuller GN, Kros JM (2007) Gliomatosis cerebri. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. World Health Organization, Lyon, France, pp 50–52Google Scholar
  7. 7.
    Chamberlain MC (2003) Combined-modality treatment of leptomeningeal gliomatosis. Neurosurgery 52:324–329CrossRefPubMedGoogle Scholar
  8. 8.
    Pradat PF, Hoang-Xuan K, Cornu P, Mokhtari K, Martin-Duverneuil N, Poisson M, Delattre JY (1999) Treatment of meningeal gliomatosis. J Neurooncol 44:163–168CrossRefPubMedGoogle Scholar
  9. 9.
    Park S, Suh YL, Nam DH, Kim ST (2009) Gliomatosis cerebri: clinicopathologic study of 33 cases and comparison of mass forming and diffuse types. Clin Neuropathol 28:73–82PubMedGoogle Scholar
  10. 10.
    Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY (2004) Initial chemotherapy in gliomatosis cerebri. Neurology 63:270–275PubMedGoogle Scholar
  11. 11.
    Levin N, Gomori JM, Siegal T (2004) Chemotherapy as initial treatment in gliomatosis cerebri—results with temozolomide. Neurology 63:354–356PubMedGoogle Scholar
  12. 12.
    Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MH (2003) Gliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys 56:1137–1146CrossRefPubMedGoogle Scholar
  13. 13.
    Taillibert S, Chodkiewicz C, Laigle-Donadey F, Napolitano M, Cartalat-Carel S, Sanson M (2006) Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature. J Neurooncol 76:201–205CrossRefPubMedGoogle Scholar
  14. 14.
    Onda K, Tanaka R, Takahashi H, Takeda N, Ikuta F (1989) Cerebral glioblastoma with cerebrospinal-fluid dissemination—a clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery 25:533–540CrossRefPubMedGoogle Scholar
  15. 15.
    Yung WKA, Horten BC, Shapiro WR (1980) Meningeal gliomatosis—a review of 12 cases. Ann Neurol 8:605–608CrossRefPubMedGoogle Scholar
  16. 16.
    Arita N, Taneda M, Hayakawa T (1994) Leptomeningeal dissemination of malignant gliomas—incidence, diagnosis and outcome. Acta Neurochir (Wien) 126:84–92CrossRefGoogle Scholar
  17. 17.
    Jennings MT, Frenchman M, Shehab T, Johnson MD, Creasy J, LaPorte K, Dettbarn WD (1995) Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol 10:37–45CrossRefPubMedGoogle Scholar
  18. 18.
    Yomo S, Tada T, Hirayama S, Tachibana N, Otani M, Tanaka Y, Hongo K (2007) A case report and review of the literature. J Neurooncol 81:209–216CrossRefPubMedGoogle Scholar
  19. 19.
    Davila G, Duyckaerts C, Lazareth JP, Poisson M, Delattre JY (1993) Diffuse primary leptomeningeal gliomatosis. J Neurooncol 15:45–49CrossRefPubMedGoogle Scholar
  20. 20.
    Dietrich PY, Aapro MS, Rieder A, Pizzolato GP (1993) Primary diffuse leptomeningeal gliomatosis (PDLG): a neoplastic cause of chronic meningitis. J Neurooncol 15:275–283CrossRefPubMedGoogle Scholar
  21. 21.
    Beauchesne P, Pialat J, Duthel R, Barral FG, Clavreul G, Schmitt T, Laurent B (1998) Aggressive treatment with complete remission in primary diffuse leptomeningeal gliomatosis—a case report. J Neurooncol 37:161–167CrossRefPubMedGoogle Scholar
  22. 22.
    Yip M, Fisch C, Lamarche JB (2003) AFIP archives: gliomatosis cerebri affecting the entire neuraxis. Radiographics 23:247–253PubMedGoogle Scholar
  23. 23.
    Grant R, Naylor B, Junck L, Greenberg HS (1992) Clinical outcome in aggressively treated meningeal gliomatosis. Neurology 42:252–254PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Matthew K. Knox
    • 1
  • Cynthia Ménard
    • 2
  • Warren P. Mason
    • 3
  1. 1.Faculty of Medicine, UME Office, Health Sciences CentreUniversity of CalgaryCalgaryCanada
  2. 2.Department of Radiation Oncology, Radiation Medicine Program, Princess Margaret HospitalUniversity of TorontoTorontoCanada
  3. 3.Department of Medicine, Princess Margaret HospitalUniversity of TorontoTorontoCanada

Personalised recommendations